Substrate
Topic

FDA approvals

4 stories related to this topic, newest first.

Trump Administration Eases Federal Restrictions on Medical Marijuana Amid Widespread Use for Pain ManagementFabrice Florin from Mill Valley, USA / Wikimedia (CC BY-SA 2.0)
health1 day agoDeveloping

Trump Administration Eases Federal Restrictions on Medical Marijuana Amid Widespread Use for Pain Management

President Trump has recently eased restrictions on medical marijuana, which millions of Americans use to treat chronic pain and other conditions. The Food and Drug Administration has approved a limited number of cannabis-based drugs for specific ailments. Experts note potential b…

The New York Times
1 source
FDA Greenlights First U.S. Trial of Ibogaine Derivative for Treating Alcohol Use DisorderSubstrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)
finance10 days agoDeveloping

FDA Greenlights First U.S. Trial of Ibogaine Derivative for Treating Alcohol Use Disorder

The Food and Drug Administration has greenlit the first human clinical trial of an ibogaine derivative in the United States to test its potential as a treatment for alcohol use disorder. This follows President Trump's executive order to fast-track psychedelic research. The agency…

New York Post
fortune.com
2 sources
FDA Approves Addyi for Women Under 65Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)
science12 days agoFraming55Framing risk55/100Rewrite inherits 'controversial' framing from sources and foregrounds marketing process over approval substance, introducing mild skepticism via expert quote.Click to jump to full framing analysis

FDA Approves Addyi for Women Under 65

The Food and Drug Administration has expanded the use of Addyi, a drug treating low libido, to all women under 65. Sprout Pharmaceuticals is promoting discounted telehealth consultations for prescriptions via Prescribery. Health experts note potential concerns with pharmaceutical…

Stat
1 source
Revolution Medicines Presents Strong KRAS Drug Data and Preclinical Compound InsightsSubstrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)
science13 days agoDeveloping

Revolution Medicines Presents Strong KRAS Drug Data and Preclinical Compound Insights

Revolution Medicines shared clinical trial success for its pancreatic cancer therapy last week and preclinical data on a new compound yesterday. The company also presented strong results for its KRAS drug at the AACR meeting on April 21, 2026. Additional biotech developments incl…

ST
1 source